Literature DB >> 7331770

In vivo effect of sera from animals with chronic relapsing experimental allergic encephalomyelitis on central and peripheral myelin.

H Lassmann, K Kitz, H M Wisniewski.   

Abstract

Sera from guinea pigs with acute or chronic relapsing experimental allergic encephalomyelitis (EAE) were injected into lumbosacral subarachnoid space of normal recipient rats. Seventeen of 37 sera induced demyelination in the CNS, and 27 of 37 sera caused demyelinated peripheral nerve fibers in the roots. The highest incidence of demyelinating activity of EAE sera was noted in those from donor animals sampled during the early chronic stage of the disease [40--100 days post sensitization (dps)]. Only few sera from animals sampled during the acute and subacute stage (10--40 dps) were able to induce demyelination. Sera from animals sampled between 100 and 200 dps showed a lower incidence of demyelinating activity as compared to those from the early chronic phase of the disease. There was no clear-cut correlation between the serum-demyelinating activity and the severity of the demyelinating disease in the donor animals. The patterns of demyelination in the central as well as peripheral nervous system of recipient animals were characterized by vesicular disruption of myelin or myelin stripping. Myelin degradation was performed mainly be macrophages. In the CNS some astrocytes also contained debris. Astrocytes increased in size, and mitosis of astrocytes was observed. Oligodendrocytes appeared to be unaffected. No demyelination was found when the sera from animals sensitized with CFA alone or with guinea pig liver tissue were injected into the subarachnoid space of normal recipient rats. Two possible mechanisms of demyelination are discussed: Antibody-mediated complement-dependent and antibody-dependent cell-mediated demyelination.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7331770     DOI: 10.1007/bf00690994

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  25 in total

1.  Vesicular disruption of myelin in autoimmune demyelination.

Authors:  M C Dalcanto; H M Wiśniewski; A B Johnson; S W Brostoff; C S Raine
Journal:  J Neurol Sci       Date:  1975-03       Impact factor: 3.181

2.  Passive transfer of "allergic" encephalomyelitis with antibrain serum injected into the lateral ventricle of the brain.

Authors:  B D Janković; M Draskoci; M Jancić
Journal:  Nature       Date:  1965-07-24       Impact factor: 49.962

3.  An ultrastructural study of experimental demyelination and remyelination. I. Acute experimental allergic encephalomyelitis in the peripheral nervous system.

Authors:  H Wiśniewski; J Prineas; C S Raine
Journal:  Lab Invest       Date:  1969-08       Impact factor: 5.662

4.  Structural variability of demyelinating lesions in different models of subacute and chronic experimental allergic encephalomyelitis.

Authors:  H Lassmann; K Kitz; H M Wisniewski
Journal:  Acta Neuropathol       Date:  1980       Impact factor: 17.088

5.  Chronic relapsing experimental allergic encephalomyelitis: clinicopathological comparison with multiple sclerosis.

Authors:  H Lassmann; H M Wisniewski
Journal:  Arch Neurol       Date:  1979-08

6.  In vivo demyelination by antimyelin antibodies.

Authors:  R M Williams; S Krakowka; A Koestner
Journal:  Acta Neuropathol       Date:  1980       Impact factor: 17.088

7.  Antiserum-mediated demyelination in vivo: a sequential study using intraneural injection of experimental allergic neuritis serum.

Authors:  K Saida; T Saida; M J Brown; D H Silberberg; A K Asbury
Journal:  Lab Invest       Date:  1978-11       Impact factor: 5.662

8.  Electron microscope observations on demyelination and remyelination in experimental allergic neuritis. I. Demyelination.

Authors:  R H Ballin; P K Thomas
Journal:  J Neurol Sci       Date:  1969 Jan-Feb       Impact factor: 3.181

9.  In vitro stimulation of glia cells by a lymphocyte-produced factor.

Authors:  A Fontana; A Grieder; S Arrenbrecht; P Grob
Journal:  J Neurol Sci       Date:  1980-04       Impact factor: 3.181

10.  THE APPLICATION OF TISSUE CULTURE TO THE STUDY OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS. II. SERUM FACTORS RESPONSIBLE FOR DEMYELINATION.

Authors:  S H APPEL; M B BORNSTEIN
Journal:  J Exp Med       Date:  1964-02-01       Impact factor: 14.307

View more
  14 in total

1.  Therapeutics to promote CNS repair: a natural human neuron-binding IgM regulates membrane-raft dynamics and improves motility in a mouse model of multiple sclerosis.

Authors:  Xiaohua Xu; Aleksandar Denic; Arthur E Warrington; Allan J Bieber; Moses Rodriguez
Journal:  J Clin Immunol       Date:  2012-09-19       Impact factor: 8.317

Review 2.  Are current immunological concepts of multiple sclerosis reflected by the immunopathology of its lesions?

Authors:  H Lassmann; K Vass
Journal:  Springer Semin Immunopathol       Date:  1995

3.  Intrathecal application of interferon gamma. Progressive appearance of MHC antigens within the rat nervous system.

Authors:  K Vass; H Lassmann
Journal:  Am J Pathol       Date:  1990-10       Impact factor: 4.307

4.  Necrotic changes of the spinal cord with immune-complex-mediated disseminated vasculitis in a case of atypical allergic encephalomyelitis.

Authors:  K Renkawek; J Majkowska-Wierzbicka; S Krajewski
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

5.  Myelin changes in the rats CNS following intraventricular injection of serum.

Authors:  G Konat; N H Diemer; H Offner
Journal:  Experientia       Date:  1986-01-15

6.  Chronic relapsing experimental allergic encephalomyelitis: its value as an experimental model for multiple sclerosis.

Authors:  H Lassmann
Journal:  J Neurol       Date:  1983       Impact factor: 4.849

7.  Peripheral nervous system lesions in experimental allergic encephalomyelitis. Ultrastructural distribution of T cells and Ia-antigen.

Authors:  H Lassmann; K Vass; C Brunner; H M Wisniewski
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

8.  Ganglioside GM1, a molecular target for immunological and toxic attacks: similarity of neuropathological lesions induced by ganglioside-antiserum and cholera toxin.

Authors:  B Schwerer; H Lassmann; K Kitz; H Bernheimer
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

9.  Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein.

Authors:  C Linington; M Bradl; H Lassmann; C Brunner; K Vass
Journal:  Am J Pathol       Date:  1988-03       Impact factor: 4.307

10.  Experimental allergic encephalomyelitis: the balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions.

Authors:  H Lassmann; C Brunner; M Bradl; C Linington
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.